Novavax’s Latecomer COVID-19 Vaccine Impresses With 90% Efficacy Result

Role As Booster Could Be Key

 
• By Andrew McConaghie
Novavax flag
The readout brings Novavax one step closer to its first ever product launch, and validation of its nanoparticle vaccine platform. • Source: Alamy

More from Business

More from Scrip